Cargando…
An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis
BACKGROUND: Osteosarcoma is the most common primary bone cancer and has a broad spectrum of histological subtypes. Stathmin 1 (STMN1) is a cytosolic phosphoprotein that is expressed in several types of cancer. The aim of this study was to evaluate the expression levels of STMN1 in osteosarcoma with...
Autores principales: | Zhao, Changlei, Li, Hailing, Wang, Lingling, Sun, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129035/ https://www.ncbi.nlm.nih.gov/pubmed/30169496 http://dx.doi.org/10.12659/MSM.910953 |
Ejemplares similares
-
Immunohistochemical expression of stathmin in oral dysplasia: An original study with an insight of its action on microtubules
por: Vadla, Purnima, et al.
Publicado: (2021) -
Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis
por: Kouzu, Y, et al.
Publicado: (2006) -
Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma
por: Watanabe, Akira, et al.
Publicado: (2014) -
Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer
por: Nie, Lekai, et al.
Publicado: (2022) -
Stathmin! An Immunohistochemical Analysis of the Novel Marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia
por: Vadla, Purnima, et al.
Publicado: (2020)